Start |  Archive |  Services |  About Us |  Contact

Search News

Cardiovascular Outcomes from the Latest COX-2 Randomized Trials

Results suggest that long-term use increases risk for cardiovascular thrombotic events in clinically stable patients and that short-term use increases risk in clinically unstable patients.

Continue to Cardiovascular Outcomes from the Latest COX-2 Randomized Trials on Medscape Headlines.

Your health is news!

Medical buzz is a member of the HarWester Network.